Biota Pharmaceuticals, Inc. releases salary data. CEO sees compensation rise 110%
Biota Pharmaceuticals, Inc. just filed its annual proxy statement, which details the salary information of its key executives. In 2015, the company's CEO made 1,479,427.The table is included below:
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
($) |
Stock
Awards ($) (1) |
Option
Awards ($) (1) |
All Other
Compensation ($) |
Total
($)
|
|||||||||||||||||||
Joseph M. Patti
(3)
|
2015
|
477,000 | 431,250 | — | 797,098 | 32,829 | (4) | 1,479,427 | ||||||||||||||||||
President, Chief Executive Officer and Director
|
2014
|
408,000 | — | 120,156 | 149,375 | 25,995 | (4) | 703,526 | ||||||||||||||||||
2013
|
255,385 | 37,500 | 291,660 | 853,596 | 17,244 | (4) | 1,455,385 | |||||||||||||||||||
Russell H. Plumb
(2)
|
2015
|
318,750 | 172,500 | 98,000 | — | 30,080 | (5) | 878,080 | ||||||||||||||||||
Executive Chairman and Director
|
2014
|
525,000 | — | 192,250 | 239,000 | 28,256 | (5) | 984,506 | ||||||||||||||||||
2013
|
335,192 | 60,000 | 583,321 | 1,365,753 | 19,431 | (5) | 2,363,697 |
Sweet. His salary increase must be approximately inversely proportional to the destruction of shareholder equity. Performance-based remuneration? Nothing like crony capitalism is there?
ReplyDelete